SMTL ID : 7r7i.2 (1 other biounit)

Structure of human SHP2 in complex with compound 27

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.85 Å

Oligo State

monomer

Ligands

1 x 3CW: [3-(4-amino-4-methylpiperidin-1-yl)-6-(2,3-dichlorophenyl)-5-methylpyrazin-2-yl]methanol(Non-covalent)

3CW.1: 16 residues within 4Å: Chain A: E.116, R.117, F.119, H.120, L.222, N.223, T.224, T.225, E.255, E.256, T.259, L.260, Q.263, P.497, K.498, Q.501 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:T.259, A:L.260, A:P.497, A:K.498, A:Q.501 Hydrogen bonds: A:F.119, A:L.222, A:T.224, A:T.225 Water bridges: A:R.117, A:N.223, A:E.255 pi-Cation interactions: A:R.117 Halogen bonds: A:T.259

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Czako, B. et al., Discovery of 6-[(3 S ,4 S )-4-Amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-3-(2,3-dichlorophenyl)-2-methyl-3,4-dihydropyrimidin-4-one (IACS-15414), a Potent and Orally Bioavailable SHP2 Inhibitor. J.Med.Chem. (2021)

Release Date

2021-10-27

Peptides

Tyrosine-protein phosphatase non-receptor type 11: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Tyrosine-protein phosphatase non-receptor type 11

Related Entries With Identical Sequence